Biotech Values

[Fred Kadiddlehopper]

I would imagine MYNZ's ColoAlert is a shoo-in for US approval. I'd forgotten about the lab processing issue, but I'm holding my fire on that despite the clear logic of yours. Time will tell if QC really suffers. My main (pun not actually intended) concern about MYNZ is another observation of yours about the more generalized difficulty for medical device companies in turning a profit. Consequently, I'm still watchfully on the sidelines in this space.